Mays Cancer Center leads a study evaluating Phase I and Phase III clinical trials for

[News]

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer.

More... (https://www.news-medical.net/news/20230201/Mays-Cancer-Center-leads-a-study-evaluating-Phase-I-and-Phase-III-clinical-trials-for-breast-cancer-drug.aspx)